8 results
8-K
EX-99.1
ARCT
Arcturus Therapeutics Holdings Inc
1 Nov 22
Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
6:36pm
combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live … preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, and leading R&D capabilities, CSL Seqirus utilizes egg, cell
10-K
x3ek7s
16 Mar 20
Annual report
11:09am
- Prev
- 1
- Next